Meggitt Rating Reiterated by Cantor Fitzgerald Europe (MGGT)
Meggitt (LON:MGGT)‘s stock had its “buy” rating restated by equities research analysts at Cantor Fitzgerald Europe in a research note issued to investors on Thursday, American Banking News reports. They currently have a GBX 590 ($9.72) price objective on the stock. Cantor Fitzgerald Europe’s price objective would indicate a potential upside of 9.87% from the company’s current price.
MGGT has been the subject of a number of other recent research reports. Analysts at JPMorgan Chase & Co. raised their price target on shares of Meggitt from GBX 555 ($9.15) to GBX 575 ($9.48) in a research note to investors on Wednesday. They now have a “neutral” rating on the stock. Separately, analysts at Investec raised their price target on shares of Meggitt from GBX 535 ($8.82) to GBX 540 ($8.90) in a research note to investors on Monday. They now have a “hold” rating on the stock. Finally, analysts at Deutsche Bank raised their price target on shares of Meggitt from GBX 500 ($8.24) to GBX 510 ($8.40) in a research note to investors on Thursday, December 5th. They now have a “hold” rating on the stock. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and five have issued a buy rating to the stock. Meggitt has a consensus rating of “Hold” and an average target price of GBX 540.80 ($8.91).
Meggitt (LON:MGGT) traded up 0.09% on Thursday, hitting GBX 537.50. The stock had a trading volume of 367,275 shares. Meggitt has a one year low of GBX 413.20 and a one year high of GBX 575.00. The stock’s 50-day moving average is GBX 512.6 and its 200-day moving average is GBX 531.9. The company’s market cap is £4.233 billion.
Meggitt PLC is engaged in the design and manufacture of technology products and systems for the aerospace, defense and other specialist markets, including energy, medical, industrial, test and transportation.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.